174603-56-6

Basic information

• Product Name: 4-BROMO-6-FLUOROINDAN-1-ONE
• Synonyms: 4-BROMO-6-FLUOROINDAN-1-ONE;4-broMo-6-fluoro-2,3-dihydro-1H-inden-1-one;1H-Inden-1-one,4-broMo-6-fluoro-2,3-dihydro-;4-Bromo-6-fluoro-1-indanone
• CAS NO: 174603-56-6
• Molecular Formula: C9H6BrFO
• Molecular Weight: 229.0457432
• Mol File: 174603-56-6.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 301.069 °C at 760 mmHg
• Flash Point: 135.882 °C
• Appearance: /
• Density: 1.691 g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.599
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-BROMO-6-FLUOROINDAN-1-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-6-FLUOROINDAN-1-ONE(174603-56-6)
• EPA Substance Registry System: 4-BROMO-6-FLUOROINDAN-1-ONE(174603-56-6)

Safety Data

• Hazardous Substances Data: 174603-56-6(Hazardous Substances Data)

Usage

General Description

4-Bromo-6-fluoroindan-1-one is a chemical compound that belongs to a class of organic compounds known as indanones. These are compounds containing a carbonyl group and two carbon rings of which one is a five-membered ring attached at the 2-position. The 4-bromo-6-fluoroindan-1-one is characterized by the incorporation of bromine and fluorine atoms in its structure. It is an aromatic compound, meaning that it has a ring of atoms which contain alternating single and double bonds. Not much is documented about its other properties or uses, and hence, safety and handling precautions should be observed while dealing with this compound.

InChI:InChI=1/C9H6BrFO/c10-8-4-5(11)3-7-6(8)1-2-9(7)12/h3-4H,1-2H2

Upstream product

• 202865-73-4 2-bromo-4-fluoro-1-iodobenzene 
• 174603-54-4 2-(2-bromo-4-fluoro-benzyl)-malonic acid diethyl ester 
• 174603-55-5 3-(2-bromo-4-fluoro-phenyl)-propionic acid 
• 61150-57-0 2-bromo-4-fluorobenzyl bromide 
• 1422-53-3 2-bromo-4-fluorotoluene 

Relevant articles and documents

QUINOXALINE DERIVATIVES

The present invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.

3-ARYL-5-SUBSTITUTED-ISOQUINOLIN-1-ONE COMPOUNDS AND THEIR THERAPEUTIC USE

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 3-aryl-5-substituted- 2/-/-isoquinolin-1-one compounds that, inter alia, inhibit PARP (e.g., PARP1, TNKS1, TNKS2, e

Indanylidenes. 2. Design and synthesis of (E)-2-(4-chloro-6-fluoro-1-indanylidene)-N-methylacetamide, a potent antiinflammatory and analgesic agent without centrally acting muscle relaxant activity

Extension of the structure-activity relationship studies that led to the discovery of the nonsedating potent muscle relaxant, antiinflammatory, and analgesic agent (E)-2-(4,6-difluoro-1-indanylidene)acetamide, 1, has given rise to (E)-2-(4-chloro-6-fluoro